Enjoy your project.
Synapse is a firm specialized in the high quality management of complex research and development projects in the biomedical sector.
Synapse partners with national and international organisations, both public and private. Our company goes beyond classical project management and brings in added value capabilities in team management, vision management, strategic thinking and project intelligence. Synapse’s expertise extends to market knowledge, business planning and valorization of research results.
Enjoy your project
We believe a research project should be an enjoyable experience for all partners.
Without ideas there is nothing to manage
For us a good scientific idea is the essential pillar and the origin for any successful and enjoyable project.
Partnership VS Service
We aim to provide an excellent personalized service, but we see ourselves as a committed partner – together we pursue mutual benefit.
Knowledge
Our structure is based on our broad experience and knowledge in the project management field.
Leveraging your leadership
Leading a complex research project with multiple stakeholders from a very diverse range of environments and countries is not an easy task.
OUR PROJECTS
-
ERA4TB
European Accelerator of Tuberculosis Regime The main objective of ERA4TB is to create a European open platform to... -
NEURONET
Efficiently Networking European Neurodegeneration Research The main aim of NEURONET is to set up an efficient platform to... -
TransBioLine
Innovative Medicines Initiative Launches Translational Safety Biomarker Pipeline Project To Enable Development And Implementation Of Novel Safety Biomarkers... -
HTx
Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health... -
EHDEN
European Health Data & Evidence Network The mission of EHDEN is to provide a new paradigm for the... -
eTRANSAFE
Enhancing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFE project aims to develop an advanced data integration infrastructure... -
Drive
Development of Robust and Innovative Vaccine Effectiveness DRIVE aims at developing a governance model between public and private... -
TransQST
TransQST aims to develop novel computational approaches using the best available data from the public and private domains... -
HARMONY
Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY HARMONY aims at capturing, integrating, analysing and harmonising... -
AMYPAD
Amyloid imaging to prevent Alzheimer’s Disease The Amyloid imaging to prevent Alzheimer’s Disease (AMYPAD) project aims at studying...
OUR PARTNERS










LATEST NEWS
-
Synapse organized the Neuronet Working Group meeting on sustainability
Feb 8, 2021
An online event where projects had the opportunity to share their sustainability plans. On January 25th, Neuronet hosted... -
Announcing the launch of NEURONET Knowledge Base
Feb 1, 2021
The members of the Neuronet (Efficiently Networking European Neurodegeneration Research) programme are pleased to announce the launch of... -
Neuronet annual event at the 30th Alzheimer Europe Conference
Oct 28, 2020
This year the 30th Alzheimer Europe Conference was hosted online from 20 to 22 October 2020. The Neuronet... -
The HARMONY Alliance launches HARMONY PLUS, a new public-private partnership to improve outcomes for patients with blood cancers
Oct 7, 2020
HARMONY PLUS builds upon the success of HARMONY in capitalizing on Big Data to speed up the development... -
Neuronet convenes 5th meeting of its Scientific Coordination Board
Oct 6, 2020
Our Scientific Coordination Board (also known as the SCB) plays a central role in determining how we direct our efforts.... -
3rd DRIVE Annual Forum 2020
Oct 6, 2020
More than 140 experts came together on the 22nd and 24th of September 2020 for DRIVE’s third Annual Forum. This included... -
Synapse now ranks as the #1 SME in Europe in the Health domain
Sep 1, 2020
Horizon 2020 (H2020) is the biggest EU Research and Innovation programme with €77 billion of funding available over... -
HARMONY Alliance, European Public-private Partnership for Big Data in Hematology, Welcomes Pfizer as New Partner
Jun 11, 2020
Pfizer joins the more than 50 other partners committed to accelerating the development of new treatments and enable... -
Call for tenders 2020/2021 – DRIVE invites study sites interested in researching influenza vaccine effectiveness to join the network – apply now!
Feb 4, 2020
DRIVE Call for Tenders is now open for sites for studying influenza vaccine effectiveness. The purpose of the... -
ERA4TB, an international consortium to accelerate the development of comprehensive treatments against tuberculosis
Feb 2, 2020
More than 30 partners from 13 countries participate in the ERA4TB project The ERA4TB (European Regimen Accelerator for Tuberculosis)...